Hypermanganesaemia with dystonia polycythemia and cirrhosis

J Pak Med Assoc. 2022 Oct;72(10):2097-2100. doi: 10.47391/JPMA.1776.

Abstract

Hypermanganesaemia with dystonia, polycythemia, and cirrhosis (HMDPC) is a rare genetic and autosomal recessive disorder that occurs due to mutation of the SLC3A10 gene, which encodes the manganese (Mn) transporter in the body; as a result, Mn accumulates in the brain, liver and muscles. This accumulation leads to symptoms of generalized dystonia, polycythemia, and hypermanganesaemia. In this report, we present the case of a 2½-year-old baby girl (patient) with complaints of lower limb weakness and increased difficulty in walking for six months. Her laboratory test results showed deranged values with increased Mn levels in the body. The patient was put on six cycles of EDTA therapy, which showed an improvement in her condition. This case report is presented to create awareness about a rare genetic disorder with an effective treatment in some cases. Thus, more work and research is required to understand and develop better treatment options for this disease.

Keywords: Hypermanganesemia, Dystonia and polycythemia..

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cation Transport Proteins* / genetics
  • Dystonia* / genetics
  • Dystonic Disorders*
  • Female
  • Humans
  • Liver Cirrhosis / complications
  • Manganese / metabolism
  • Metabolic Diseases*
  • Mutation
  • Polycythemia*
  • Young Adult

Substances

  • Cation Transport Proteins
  • Manganese